Literature DB >> 423142

Comparison of antineoplastic activity of aminoethylaminoanthraquinones and anthracycline antibiotics.

C C Cheng, G Zbinden, R K Zee-Cheng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 423142     DOI： 10.1002/jps.2600680344

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  18 in total

Review 1.  Cancer chemotherapy: new developments and changing concepts.

Authors:  S K Carter
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

2.  Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study.

Authors:  H T Mouridsen; M Cornbleet; R Stuart-Harris; I Smith; R Coleman; R Rubens; M McDonald; H Rainer; A van Oosterom; J Smyth
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

3.  Prospective study of left ventricular function using radionuclide scans in patients receiving mitoxantrone.

Authors:  M S Aapro; D S Alberts; J M Woolfenden; C Mackel
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

4.  Investigation of the interaction of cardiotoxic anticancer agents using the fetal mouse heart organ culture system.

Authors:  B F Kimler; R D Rethorst; G G Cox
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

5.  A phase I trial of ametantrone acetate (NSC-287513).

Authors:  R A Gams; F Ostroy; J F Bender; A J Grillo-López
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

6.  Mitoxantrone: an active new agent in the treatment of advanced breast cancer.

Authors:  R C Stuart-Harris; T Bozek; N A Pavlidis; I E Smith
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

7.  Mitoxantrone in the treatment of relapsed and refractory acute leukemia.

Authors:  P Meyer; A D Ho; G Ehninger; I Mjaaland; E Heidemann; E Seither
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

8.  Plasma kinetics of mitoxantrone in leukemic patients.

Authors:  R Hulhoven; E Dumont; C Harvengt
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

9.  Pharmacokinetics of ametantrone acetate (NSC-287513).

Authors:  J G Kuhn; C E Balmer; T M Ludden; D M Loesch; D D Von Hoff; J F Bender; A J Grillo-Lopez
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro.

Authors:  B T Hill; L K Hosking; S A Shellard; R D Whelan
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.